DTaP/IPV (Infanrix®-IPV or Repevax®) : PGD template
- Public Health England
- Part of:
- Immunisation patient group direction (PGD) templates
- First published:
- 7 January 2016
PGD template to support the national diphtheria, tetanus, pertussis and poliomyelitis vaccination programme.
Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (DTaP/IPV or dTaP/IPV): patient group direction (PGD) template
Ref: PHE publications gateway number: 2015560 MS Word Document, 189KB
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
This patient group direction (PGD) template is to support the administration of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (DTaP/IPV or dTaP/IPV) by currently registered nurses or paramedics. This applies to individuals from 3 years 4 months to under 10 years of age, in accordance with the national immunisation programme. It is valid from 15 December 2015 to 30 November 2017.
The PGD template requires further authorisation by a clinical governance or patient safety lead, who has designated responsibility for signing PGDs on behalf of NHS England for their geographical area. The PGD is not legal or valid without this local, formal authorisation.
Adoption and governance of the use of this PGD is the responsibility of the authorising commissioning body and providers.
Provider organisations, health professionals and immunisation practitioners should check they are working to the current PGD versions and only work to a legally authorised PGD from their commissioning body.
Published: 7 January 2016